Selected cases where infringement exists, but a federal judge permits ongoing infringement. 2006. June 14: z4 Techs., Inc. v. Microsoft Corp., 434 F. Supp. 2d 437, 439 (E.D. Tex. 2006) Patents 6,044,471 and 6,785,825 disclose methods for limiting the unauthorized… Continue Reading →
On April 19, 2019, HealthGap, Knowledge Ecology International, Public Citizen, Social Security Works and the Union for Affordable Cancer Treatment filed comments on a proposed license on National Cancer Institute patented inventions to Senti Bio, for a next generation CAR… Continue Reading →
In an order dated April 11, 2019, Judge Peter J. Messitte granted the NIH’s motion to dismiss for lack of jurisdiction in the lawsuit filed by KEI, which appealed an NIH decision to grant an exclusive license on a CAR… Continue Reading →
This timeline provides copies of official documents not published before about the U.S. pressures in the Dominican Republic during the congressional debates that led to the adoption of the TRIPS-implementing legislation Law 20-00. These documents were obtained via FOIA requests.… Continue Reading →
HOUSE REPORT NO. 96-1307 (Part II), SEPT. 23, 1980 Additional views of Honorable Jack Brooks The major problem I have with H.R. 6933 is that it violates a basic provision of the unwritten contract between the citizens of this country… Continue Reading →
PhRMA’s Special 301 submissions are part of a yearly ritual to shape the “Special 301” Report, an annual review of the global state of intellectual property rights (IPR) protection and enforcement, conducted by the Office of the United States Trade… Continue Reading →
(UPDATE: The NIH provided a response to our comments on February 26, 2019) On February 22, 2019, KEI submitted comments to the Federal Register notice 84 FR 2555 on the “Prospective Grant of an Exclusive Patent License: Virus-Like Particles Vaccines… Continue Reading →
(UPDATE: The NIH provided a response to our comments on March 11, 2019) On February 22, 2019, Knowledge Ecology International (KEI), Public Citizen, Social Security Works (SSW) and the Union for Affordable Cancer Treatment (UACT) jointly submitted comments to the… Continue Reading →
On 8 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/652) by Australia; Canada; Chile; The European Union; Hong Kong, China; Japan; the Republic of Korea; Singapore; Switzerland; Chinese Taipei; and the United States to the TRIPS Council… Continue Reading →
On 18 December 2018, the World Health Organization (WHO) published a “Technical report on Pricing of cancer medicines and its impacts” (hereinafter referred to as the “WHO Cancer Report”). The mandate for the WHO Cancer Report emanates from operative paragraph… Continue Reading →